Continuous infusion of cefotaxime lead to better PK target attainment versus intermittent infusion in critically ill patients. ( Aardema H. and al. )
Continuous versus intermittent infusion of cefotaxime in critically ill patients: a randomized controlled trial comparing plasma concentrations.
| Dr Jean-Pierre Bru To date, only two observational studies on cefotaxime dosing in critical care populations are available, none of them compared continuous … Suite